Williams v. Boehringer Ingelheim Pharmaceuticals, Inc.
Petition for certiorari denied on February 20, 2024
Issue: Whether an interlocutory ruling that dismisses some (but not all) of a plaintiff’s claims with prejudice become an appealable “final decision” if the plaintiff voluntarily dismisses her action under Federal Rule of Civil Procedure 41(a).
| Date | Proceedings and Orders (key to color coding) |
|---|
| Jul 25 2023 | Application (23A79) to extend the time to file a petition for a writ of certiorari from August 16, 2023 to October 15, 2023, submitted to Justice Thomas. |
| Jul 27 2023 | Application (23A79) granted by Justice Thomas extending the time to file until September 15, 2023. |
| Sep 15 2023 | Petition for a writ of certiorari filed. (Response due October 20, 2023) |
| Oct 16 2023 | Waiver of right of respondents Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corp. to respond filed. |
| Nov 01 2023 | DISTRIBUTED for Conference of 11/17/2023. |
| Nov 06 2023 | Response Requested. (Due December 6, 2023) |
| Nov 13 2023 | Motion to extend the time to file a response from December 6, 2023 to December 22, 2023, submitted to The Clerk. |
| Nov 14 2023 | Motion to extend the time to file a response is granted and the time is extended to and including December 22, 2023. |
| Dec 21 2023 | Brief of respondents Boehringer Ingelheim Pharmaceuticals, Inc. et al. in opposition filed. |
| Jan 04 2024 | Reply of petitioner Marilyn Williams filed. |
| Jan 10 2024 | DISTRIBUTED for Conference of 2/16/2024. |
| Feb 20 2024 | Petition DENIED. |
